Evolus to Participate in Canaccord Genuity’s 43rd Annual Growth Conference
26 Julho 2023 - 9:45AM
Business Wire
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a
focus on building an aesthetic portfolio of consumer brands, today
announced that members of its management team will be participating
in Canaccord Genuity’s 43rd Annual Growth Conference in Boston.
Event: Canaccord Genuity’s 43rd Annual Growth
Conference Date: Wednesday, August 9, 2023 Time: 8:30 – 8:55 am
ET
An audio webcast of this event will be available on the investor
relations section of Evolus’ website at www.evolus.com. A replay of
the webcast will be available for 90 days after the date of the
presentation.
About Evolus, Inc.
Evolus (Nasdaq: EOLS) is a performance beauty company evolving
the aesthetic neurotoxin market for the next generation of beauty
consumers through its unique, customer-centric business model and
innovative digital platform. Our mission is to become a global,
multi-product aesthetics company based on our flagship product,
Jeuveau® (prabotulinumtoxinA-xvfs), globally licensed under the
brand name Nuceiva®. The product is manufactured in a
state-of-the-art facility using Hi-Pure™ technology. Evolus is
expanding its product portfolio having entered into a definitive
agreement to be the exclusive U.S. distributor of Evolysse™, a line
of five unique dermal fillers currently in late-stage development.
Visit us at www.evolus.com, and follow us on LinkedIn, Twitter,
Instagram or Facebook.
Jeuveau® and Nuceiva® are registered trademarks of Evolus, Inc.
Evolysse™ is a trademark of Evolus, Inc. Hi-Pure™ is a trademark of
Daewoong Pharmaceutical Co, Ltd.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230721606063/en/
Investor Contact: David K. Erickson
Vice President, Investor Relations Tel: 949-966-1798 Email:
david.erickson@evolus.com
Media Contact: Email:
media@evolus.com
Evolus (NASDAQ:EOLS)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Evolus (NASDAQ:EOLS)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024